search
for
 About Bioline  All Journals  Testimonials  Membership  News


Rwanda Medical Journal
Rwanda Health Communication Center - Rwanda Biomedical Center (RHCC - RBC)
ISSN: 2079-097X
EISSN: 2079-097X
Vol. 68, No. 3, 2010, pp. 25-31
Bioline Code: rw10018
Full paper language: English
Document type: Research Article
Document available free of charge

Rwanda Medical Journal, Vol. 68, No. 3, 2010, pp. 25-31

 fr
Kakoma, J.B.; Gasana, G.K.; Nkurunzinza, J. & Ngirinshuti, J.P.

Résumé

La dysménorrhée ou les règles douloureuses n’est pas mortelle, mais elle est la plupart du temps débilitante et psychologiquement éprouvante pour les femmes. Cette première étude vise à souligner les aspects épidémiologiques, cliniques et thérapeutiques ainsi que l’impact social, l’attitude, la conscience et la connaissance du traitement chez les étudiantes et élèves (Province du Sud / Rwanda). En outre, quelques autres caractéristiques menstruelles ont été relevées chez les dysménorrhéiques et non dysménorrhéiques. Il s’agit d’une étude transversale, descriptive et analytique. La population d’étude est constituée par deux groupes interviewés au cours de deux enquêtes menées conjointement: (1) 466 étudiantes de l’Université Nationale du Rwanda qui avaient accepté de participer à l’enquête et de répondre au questionnaire; (2) 423 adolescentes et jeunes filles des pensionnats de la ville de Nyanza (77 d’entre elles avaient été exclues à cause des questionnaires incomplets). La dysmenorrhée était considerée dans son ensemble sans faire la distinction entre dysmenorrhée primaire et secondaire. L’analyse statistique s’est appuyée sur les éléments suivants : le calcul du RR et l’ IC à 95 %, le test de Chi carré (avec correction de Yates) et le test exact de Fisher pour comparer les proportions observées ainsi que le test t de Student pour comparer deux moyennes des données normalement distribuées. Les résultats suivants étaient observés chez les étudiantes et les adolescentes: (1) prévalence de la dysménorrhée (77.3% vs 85.6 %; p = 0.001 ; RR = 0.90 [0.85 – 0.96]); (2) durée de la dysmenorrhée > 3 jours (21.1 % vs 39.5 %; p = 0.000 ; RR = 0.46 [0.36 – 0.58]); (3) inactivité > 3 jours (16.4 % vs 41.1 % ; p = 0.000 ; RR = 0.36 [0.27 – 0.46]); (4) absentéisme(60.5 % - 61 %; p = 0.891 ; RR = 0.99 [0.88 – 1.12]); (5) examens manqués (11.6 % vs 39.5 %; p = 0.000 ; RR = 0.30 [0.22 – 0.40]); (6) diminution de la douleur (7.2 % vs 20.6 %; p = 0.000 ; RR = 0.30 [0.20 – 0.45]); (7) automédication (31.1 % vs 23.2 %; p = 0.169 ; RR = 1.34 [1.05 – 1.71]); (8) résignation (48.1 % vs 59.4 %; p = 0.002 ; RR = 0.81 [0.71 – 0.93]); (9) hospitalisation (5.3 % vs 46 %; p = 0.000 ; RR = 0.17 [0.06 – 0.46]); (10) sensibilité au traitement (60.8 % vs 48.3 %; p = 0.000 ; RR = 1.26 [1.10 – 1.44]); (11) analgésiques (39.4 % vs 26.2 %; p = 0.013 ; RR = 1.29 [1.05 – 1.57]); (12) anti-inflammatoires non stéroïdiens (38.8 % vs 16.7 %; p = 0.000 ; RR = 1.98 [1.55 – 2.53]); (13) antispasmodiques (17.5 % vs 12.2 %; p = 0.249 ; RR = 1.22 [0.87 – 1.71]); (14) aspirine (3.8 % vs 4 %; p = 0.986; RR = 1.01 [0.53 – 1.90]); (14) âge de la ménarche (14.4 ± 1.7 vs 14.5 ± 1.9 ans; p > 0.2); (15) durée de la menstruation > 3 jours (56.7 % vs 44.7 %; p = 0.000 ; RR = 1.27 [1.11 – 1.45]); (16) ménarche < 12 ans (5.8 % vs 5.6 %; p = 0.56 ; RR = 1.13 [0.75 – 1.70]); (17) ménarche > 16 ans (9.8 % vs 8.7 %; p = 0.56 ; RR = 1.13 [0.75 – 1.70]); (18) polyménorrhée (19.7 5 vs 33.8 %; p = 0.000 ; RR = 0.58 [0.47 – 0.73]); (19) céphalées (34.5 % vs 55.3 %; p = 0.000 ; RR = 0.62 [0.54 – 0.73]); (20) vomissements (17.6 % vs 31.6 %; p = 0.000 ; RR = 0.56 [0.44 – 0.71]); (21) malaise (47.2% vs 24.5 %; p = 0.000 ; RR = 1.92 [1.58 – 2.33]); (22) somnolence (22.8 % vs 40.8 %; p = 0.000 ; RR = 0.51 [0.41 – 0.63]); (23) troubles du comportement (37.3 % vs 12.5 %; p = 0.000 ; RR = 2.98 [2.26 – 3.93]). En conclusion, la dysménorrhée est plus fréquente et sa durée plus longue chez les adolescentes et jeunes filles des écoles secondaires que chez les étudiantes dans la partie méridionale du Rwanda. Elle représente un vrai problème de santé publique se traduisant par un taux élevé d’absentéisme et d’inactivité, des examens manqués, voire des cas d’hospitalisation ; cet impact négatif ainsi que la plupart des symptômes désagréables sont significativement plus retrouvés chez les élèves de l’école secondaire que chez les étudiantes de l’université. Une campagne d’information s’impose en vue de minimiser l’absence de prise de conscience du traitement et le niveau de résignation. L’âge de la ménarche et les autres caractéristiques menstruelles se situent dans les limites observées ailleurs dans le monde, sauf que la prévalence de la puberté précoce est deux fois inférieure dans notre série. En plus, il est recommandé de réaliser des enquêtes similaires dans d’autres régions du Rwanda.

Mots Clés
Dysménorrhée; Rwanda; Adolescentes; Etudiantes; Menstruation

 
 en DYSMENORRHEA AND OTHER MENSTRUAL CHARACTERISTICS IN RWANDAN FEMALE STUDENTS AT NATIONAL UNIVERSITY OF RWANDA AND NYANZA SCHOOLGIRLS (Huye and Nyanza Districts / Southern Province of Rwanda)
Kakoma, J.B.; Gasana, G.K.; Nkurunzinza, J. & Ngirinshuti, J.P.

Abstract

Dysmenorrhea or the syndrome of painful menstruation is not life-threatening, but it is most of the time debilitating and psychologically taxing for women. This first study aims to bring out epidemiological, clinical, and therapeutical aspects, as well as social impacts, attitudes, awareness and knowledge of treatment in dysmenorrheic female students and adolescents in our environment (Southern Province of Rwanda). Moreover, some menstrual characteristics were also looked for in the whole study population (dysmenorrheic and non dysmenorrheic participants). This study is cross-sectional, descriptive, and analytical. The population study consisted of two groups relating to two joint surveys: (1) 466 female students (National University of Rwanda or NUR, Huye) who accepted to participate in the survey and answered the appropriate questionnaire; (2) 423 consenting schoolgirls from Nyanza boarding high schools (77 teenagers were excluded from the survey because of incomplete questionnaires). Dysmenorrhea was considered as a whole without distinction between primary and secondary dysmenorrhea. The following statistics were calculated: RR and 95 % CI, Pearson’s Chi square test (with Yates’ correction) and Fisher exact test to compare observed proportions, and Student’s t test to compare means from normal distributed data. The results in female university students as compared to secondary school girls were as following: (1) dysmenorrhea prevalence (77.3% vs 85.6 %; p = 0.001; RR = 0.90 [0.85 – 0.96]); (2) dysmenorrhea duration > 3 days (21.1 % vs 39.5 %; p = 0.000; RR = 0.46 [0.36 – 0.58]); (3) inactivity > 3 days (16.4 % vs 41.1 %; p = 0.000; RR = 0.36 [0.27 – 0.46]); (4) absenteeism (60.5 % - 61 %; p = 0.891; RR = 0.99 [0.88 – 1.12]); (5) missed exams (11.6 % vs 39.5 %; p = 0.000; RR = 0.30 [0.22 – 0.40]); (6) decreasing pain (7.2 % vs 20.6 %; p = 0.000; RR = 0.30 [0.20 – 0.45]); (7) self-medication (31.1 % vs 23.2 %; p = 0.169; RR = 1.34 [1.05 – 1.71]); (8) wait-and-see attitude (48.1 % vs 59.4 %; p = 0.002; RR = 0.81 [0.71 – 0.93]); (9) hospitalization (5.3 % vs 46 %; p = 0.000; RR = 0.17 [0.06 – 0.46]); (10) awareness of treatment (60.8 % vs 48.3 %; p = 0.000; RR = 1.26 [1.10 – 1.44]); (11) analgesics (39.4 % vs 26.2 %; p = 0.013; RR = 1.29 [1.05 – 1.57]); (12) nonsteroidal anti-inflammatory drugs (38.8 % vs 16.7 %; p = 0.000; RR = 1.98 [1.55 – 2.53]); (13) antispasmodics (17.5 % vs 12.2 %; p = 0.249; RR = 1.22 [0.87 – 1.71] ); (14) aspirin (3.8 % vs 4 %; p = 0.986; RR = 1.01 [0.53 – 1.90]); (14) age at menarche (14.4 ± 1.7 vs 14.5 ± 1.9 years; p > 0.2); (15) menstruation duration > 3 days (56.7 % vs 44.7 %; p = 0.000; RR = 1.27 [1.11 – 1.45]); (16) menarche < 12 years (5.8 % vs 5.6 %; p = 0.56; RR = 1.13 [0.75 – 1.70]); (17) menarche > 16 years (9.8 % vs 8.7 %; p = 0.56; RR = 1.13 [0.75 – 1.70]); (18) abundant menstrual flow (19.7 5 vs 33.8 %; p = 0.000; RR = 0.58 [0.47 – 0.73]); (19) headache (34.5 % vs 55.3 %; p = 0.000; RR = 0.62 [0.54 – 0.73]); (20) vomiting (17.6 % vs 31.6 %; p = 0.000; RR = 0.56 [0.44 – 0.71]); (21) malaise (47.2 % vs 24.5 %; p = 0.000; RR = 1.92 [1.58 – 2.33]); (22) somnolence (22.8 % vs 40.8 %; p = 0.000; RR = 0.51 [0.41 – 0.63]); (23) behavior problems (37.3 % vs 12.5 %; p = 0.000; RR = 2.98 [2.26 – 3.93]).In conclusion, dysmenorrhea is significantly more frequent and its duration more long in schoolgirls than in female students in the southern part of Rwanda. It represents on the whole a real public health issue resulting in a high rate of absenteeism, inactivity, missed exams, and even hospitalization; this negative impact and most of the unpleasant symptoms are significantly more frequent in schoolgirls than in female students. An information campaign is needed to alleviate the lack of treatment awareness as well as the high rate of resignation. Age at menarche and other menstrual characteristics are on the whole within the range of what is observed worldwide, except that precocious puberty is twice less frequent in our study population. Besides, it is suggested that other surveys are carried out in other parts of Rwanda.

Keywords
Dysmenorrhea; Rwanda; Schoolgirls; Female students; Menstruation

 
© Copyright 2010 - Rwanda Medical Journal
Alternative site location: http://www.rwandamedicaljournal.org

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil